期刊文献+

药物基因组学与合理用药研究进展 被引量:6

Advances of the study on pharmacogenomics and reasonable use of drugs
下载PDF
导出
摘要 目的介绍药物基因组学及其在临床制定治疗方案中的应用。方法根据有关文献 ,综合分析、归纳总结药物基因组学和临床药物基因组学的发展、研究内容及与个体化用药的关系。结果药物基因组学研究表明 ,基因多态性与药物作用多样性之间的关系非常密切。结论药物基因组学为安全、有效和合理用药提供了理论依据。 Objective To introduce pharmacogenomics and its applications to establishing clinical pharmacotherapeutic schemes.Methods Being based on the analysis of the related literature,the development and contents of pharmacogenomics and clinical pharmacogenomics and their relationship with individualized medication were summarized.Results Pharmacogenomic studies proved the relationship between the gene polymorphisms and the variety of drug effects.Conclusions Pharmacogenomics provides a theoretical basis for medication with safety,effectiveness and rationality.
出处 《沈阳药科大学学报》 CAS CSCD 2004年第1期70-75,共6页 Journal of Shenyang Pharmaceutical University
关键词 药物基因组学 合理用药 临床药物基因组学 pharmacogenonics rational medication clinical pharmacogenomics
  • 相关文献

参考文献7

二级参考文献72

  • 1增保安彦 等.-[J].蛋白质核酸酵素,2000,(45):776-783.
  • 2须田三记也 等.-[J].蛋白质核酸酵素,2000,(45):811-820.
  • 3Blackstock WP.-[J].蛋白质核酸酵素,1998,(43):2214-2214.
  • 4[1]Antonio R.Inventing the pharmacogenomics business [J].Am J Health Syst Pharm,1999,56(1):40.
  • 5[2]William E.E,Mary VR.Pharmacogenomics:translating functional genomics into rational therapeutics[J].Science,1999,296(5 439):487.
  • 6[3]David H,Fred DL.Why pharmacogenomics?why now? [J].Nat Biotechnol,1998,16(6):492.
  • 7[4]Mashall A.Genset-Abbott deal heralds pharcogenomics era[J].Nat Biotechnol,1997,15(9):829.
  • 8[5]Aris P.Pharmacogenomics and diagnostics[J].Nat Biotechnol,1998,16(8):791.
  • 9[6]Shi MM,Bleavins MR,De la iglesia FA.Technologies for detecting genetic polymorphism in pharmacogenomics[J].Mol Diagn,1999,4(4):343.
  • 10[7]Hess P,Cooper D.Impact of pharmacogenomics on the clinical laboratory[J].Mol Diagn,1999,4(4):289.

共引文献21

同被引文献34

  • 1张贵寅.药物基因组学的研究进展[J].国外医学(遗传学分册),2004,27(5):271-275. 被引量:4
  • 2王非,郑珩,杨欣,张玉彬,吴梧桐.生物信息学分析软件的开发及在药学领域的应用[J].药学进展,2002,26(1):43-48. 被引量:6
  • 3许力,王升启.药物基因组学的发展及其在个体化用药中的应用[J].国外医学(药学分册),2006,33(6):441-444. 被引量:22
  • 4Rieder M J, Taylor SL, Clark AG, et al. Sequence variation in the human angiotensin convering enzyme [ J ]. Nat Cenet, 1999,22:59 - 62.
  • 5Rieder M J,Taylor S L,Clark A G,et al.Sequence variation in the human angiotensin converting enzyme[J].Nat Genet,1999,22:59-62.
  • 6Gonzalez F J,Skoda R C,Kimura S,et a1.Characterization of the common genetic defect in humans deficient in debrisoquine metabolism[J].Nature,1988,331 (6155):442-446.
  • 7Kapp U,Yeh W C,Patterson B,et al,Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells[J].J Exp Med,1999,189(12):1939-1946.
  • 8Wilson M,Derisi J,Kristensen H H,et al.Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization[J].Proc Natl Acad Sci USA,1999,96 (22):12833-12838.
  • 9Lynch T J,Bell D W,Sordella R,et al.Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J].New Engl J Med,2004,350(21):2129-2139.
  • 10Paez J G,Janne P A,Lee J C,et al.EGFR mutations in lung cancer:correlation with clinical response to gefitinib therapy[J].Science,2004,304(5676):1497-1500.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部